Drug shortage
Sodium Acetate Injection · Milla Pharmaceuticals
FDA drug shortage · Current · updated Apr 16, 2025
Key facts
| Generic name | Sodium Acetate Injection |
|---|---|
| Proprietary name | Sodium Acetate |
| Company | Milla Pharmaceuticals |
| Presentation | Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 69784-229-10) |
| Dosage form | Injection |
| Strength | 40 mEq/20mL (2 mEq/mL) |
| Status | Current |
| Therapeutic category | Endocrinology/Metabolism Gastroenterology Pediatric Total Parenteral Nutrition |
| Package NDCs | 69784-229-10 |
| First posted | Feb 3, 2016 |
| Last updated | Apr 16, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: